Skip to Main Content

Paper Details

2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil.
J Am Coll Cardiol
2
2017
Sildenafil
Cardiology, Child, Child Advocacy, Child Health, Dose-Response Relationship, Drug, Drug Development, Drug and Narcotic Control, Humans, Hypertension, Pulmonary, Mortality, Off-Label Use, Outcome Assessment, Health Care, Pediatrics, Randomized Controlled Trials as Topic, Sildenafil Citrate, Vasodilator Agents

Datasets